Trials / Not Yet Recruiting
Not Yet RecruitingNCT07040917
A Study of CAR-T Cells in Subjects With Autoimmune Diseases
A Study to Evaluate the Safety and Efficacy of CAR-T Cells in Subjects With Autoimmune Diseases
- Status
- Not Yet Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Chinese PLA General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in Subjects with autoimmune diseases.
Detailed description
This is a single center, one-arm, open label study aiming to evaluate the safety and efficacy of CAR-T cells therapy in subjects with autoimmune diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CAR-T cell | CAR-T cell |
Timeline
- Start date
- 2025-09-30
- Primary completion
- 2027-11-30
- Completion
- 2028-04-30
- First posted
- 2025-06-27
- Last updated
- 2025-07-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07040917. Inclusion in this directory is not an endorsement.